Skip to main content

Headlines

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Eli Lilly sues over US sales of bogus Mounjaro for weight loss
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Here's What $1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth Now
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
December 15th Options Now Available For Eli Lilly (LLY)
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
January 2026 Options Now Available For Eli Lilly (LLY)
posted:
by: Nasdaq Options
#channels:: #All, #Business, #Stocks, #Nasdaq, #Options, #StockOptions, #NasdaqOptions
ANALYSIS-Wegovy launch in UK may underline Novo's need to get ahead of Lilly
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
ANALYSIS-Wegovy launch in UK may underline Novo's need to get ahead of Lilly
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Eli Lilly: Unusual Demand is Sending the Stock Higher
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Zacks Investment Ideas feature highlights: IonQ, E.L.F Beauty, Amazon, Meta Platforms and Eli Lilly
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Lilly's diabetes drug gets greenlight from UK watchdog
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Morgan Stanley Maintains Lilly (LLY) Overweight Recommendation
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Argus Research Maintains Lilly (LLY) Buy Recommendation
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Cantor Fitzgerald Reiterates Lilly (LLY) Overweight Recommendation
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Better Pharma Growth Stock: Eli Lilly vs. Merck
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks